Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Evidence supporting an altered immune response in ASD.Immunol Lett. 2015; 163: 49-55
- An exploratory examination of neonatal cytokines and chemokines as predictors of autism risk: The Early Markers for Autism study.Biol Psychiatry. 2019; 86: 255-264
- Neonatal cytokines and chemokines and risk of autism spectrum disorder: The Early Markers for Autism (EMA) study: A case-control study.J Neuroinflammation. 2014; 11: 113
- Neonatal cytokine profiles associated with autism spectrum disorder.Biol Psychiatry. 2017; 81: 442-451
- Neonatal chemokine levels and risk of autism spectrum disorders: Findings from a Danish historic birth cohort follow-up study.Cytokine. 2013; 61: 370-376
- Computer vision analysis captures atypical attention in toddlers with autism.Autism. 2019; 23: 619-628
- Biomarkers in autism spectrum disorder: the old and the new.Psychopharmacology. 2014; 231: 1201-1216
- Interferons and proinflammatory cytokines in pregnancy and fetal development.Immunity. 2018; 49: 397-412
- Maternal immune activation alters fetal brain development through interleukin-6.J Neurosci. 2007; 27: 10695-10702
- The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring.Science. 2016; 351: 933-940